TUESDAY, Oct. 8, 2024 (HealthDay News) — A recently approved targeted chemotherapy drug can significantly extend the lives of advanced breast cancer patients who have developed tumors in their brains, new clinical trial results show. On average, patients receiving the drug Enhertu (trastuzumab deruxtecan) survived more than 17 months withoutContinue Reading

MONDAY, Oct. 7, 2024 (HealthDay News) — So much for the idea that most people born today will live 100 years or more. New research shows that the dramatic increases in life expectancy seen during the 19th and 20th centuries have slowed considerably.  In the world’s longest-living populations, life expectancyContinue Reading

MONDAY, Oct. 7, 2024 (HealthDay News) — In findings that suggest inroads are being made in the battle against America’s opioid epidemic, new government data shows a 10% drop in overdose deaths. The statistics, compiled by states and posted by the U.S. Centers for Disease Control and Prevention, show just overContinue Reading